Stephen Mitchener
Net worth: 193 753 $ as of 2024-03-30
Profile
Stephen Mitchener worked as the Head of US Oncology Strategy, Partnering & Operations at Novartis Pharmaceuticals Corp.
from 2005 to 2018.
He then worked as the Chief Business Officer at Karyopharm Therapeutics, Inc. before becoming the Chief Business Officer & Senior Vice President at Axcella Health, Inc. from 2018 to 2020.
Mitchener holds a doctorate degree from The University of North Carolina at Charlotte.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-02-28 | 128,313 ( 0.11% ) | 193 753 $ | 2024-03-30 |
Former positions of Stephen Mitchener
| Companies | Position | End |
|---|---|---|
| AXCA HEALPAR | Corporate Officer/Principal | 2020-11-30 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 2018-07-31 |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
Training of Stephen Mitchener
| The University of North Carolina at Charlotte | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| AXCA HEALPAR | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- Stephen Mitchener
